Compare PPSI & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPSI | CCEL |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Managed Health Care |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 32.7M |
| IPO Year | 2008 | 2022 |
| Metric | PPSI | CCEL |
|---|---|---|
| Price | $3.25 | $3.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 70.6K | 15.6K |
| Earning Date | 05-14-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 4.53% |
| EPS Growth | ★ 1626.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $22,879,000.00 | ★ $25,384,279.00 |
| Revenue This Year | $26.84 | N/A |
| Revenue Next Year | $10.26 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $2.26 | $2.72 |
| 52 Week High | $5.70 | $6.65 |
| Indicator | PPSI | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 57.91 |
| Support Level | $2.96 | $3.33 |
| Resistance Level | $4.05 | $3.57 |
| Average True Range (ATR) | 0.24 | 0.17 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 12.26 | 94.49 |
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.